AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT

Search National Drug Schedule

Footnotes:
C1: drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drugs Regulations
C2: drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drugs Regulations
C3: drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drugs Regulations
C4: drug is in the Controlled Drugs and Substances Act
C5: drug is in the Regulations Under CDSA
CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations

D: drug references federal Schedule "D" for Biologics
F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
N:   drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR: drug has not been reviewed by NDSAC
PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
R:   drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
U:   drug has been reviewed by NDSAC and is unscheduled
"summary": a summary of the recommendation has been developed and is posted

 

NEW - Effective December 19, 2013, Schedule F to the Food and Drug Regulations was repealed and replaced by a list of prescription drugs, called the Prescription Drug List. Therefore, all entries in the National Drug Schedules (NDS) whose footnote indicates that they appear in Schedule F (F1/F2) should now be considered part of the Prescription Drug List (PDL).

Entries whose footnote indicates that they are "Schedule F Recommended" (FR) should now be considered recommended for addition to the PDL. Some of the "Schedule F Recommended" entries may have been added or will shortly be added to the PDL by Health Canada, but either way these entries will continue to be listed in Schedule I of the NDS.

For more information on the Prescription Drug List, please consult the Health Canada website.


 

Search by drug:
Drug Name:
Schedule:

Search by schedule:
Schedule: 

Search by glossary:
A B C D E F G H I K L M N O P Q R S T U V X Y Z

Health Canada’s Drug Product Database

Licensed Natural Health Products (NHP) Database

Natural Health Products (NHP) Exempted Products Database